Part 3Importation of risk goods
Import health standards
24Review
A person consulted under section 23(3)(b) may raise with the Director-General the question of whether scientific evidence about which the person raised a significant concern received sufficient regard in the development of the standard.
The Director-General must ensure that there is a process to establish an independent review panel to review the question of whether scientific evidence about which a person has raised a significant concern received sufficient regard in the development of the standard.
The process must deal with—
- the criteria for setting up the panel; and
- how the Director-General will appoint the panel members, including the knowledge and experience that members must have; and
- the procedures to be followed by—
- a person consulted under section 23(3)(b); and
- the panel in undertaking its review; and
- a person consulted under section 23(3)(b); and
- the reporting requirements for the panel.
If a panel reports to the Director-General, the Director-General must, as soon as reasonably practicable,—
- take the panel's findings and recommendations into account; and
- determine the issue in dispute; and
- give reasons for the determination.
Notes
- Section 24: replaced, on , by section 20 of the Biosecurity Law Reform Act 2012 (2012 No 73).